Staphylococcus lugdunensis: Difference between revisions
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
* ''Staphylococcus lugdunensis'' is a coagulase-negative staphylococcus with unusual pathogenicity resembling that of S. aureus<ref>Taha L, Stegger M, and Soderquist B. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options, European Journal of Clinical Microbiology & Infectious Diseases, May 2019. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647525/ Accessed 21 December 2020.]</ref> | |||
*A [[Gram Positive Bacteria]] | *A [[Gram Positive Bacteria]] | ||
*Causes [[endocarditis]], [[meningitis]], and [[Skin and Soft Tissue Infections]] | *Causes [[endocarditis]], [[meningitis]], and [[Skin and Soft Tissue Infections]] | ||
Revision as of 19:17, 21 December 2020
Background
- Staphylococcus lugdunensis is a coagulase-negative staphylococcus with unusual pathogenicity resembling that of S. aureus[1]
- A Gram Positive Bacteria
- Causes endocarditis, meningitis, and Skin and Soft Tissue Infections
Antibiotic Sensitivities[2]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
References
- ↑ Taha L, Stegger M, and Soderquist B. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options, European Journal of Clinical Microbiology & Infectious Diseases, May 2019. Accessed 21 December 2020.
- ↑ Sanford Guide to Antimicrobial Therapy 2010